Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning
- 作者：Mei-Yun Zhang ; Vidita Choudhry ; Igor A. Sidorov ; Vladimir Tenev ; Bang K. Vu ; Anil Choudhary ; Hong Lu ; Gabriela M. Stiegler ; Hermann W.D. Katinger ; Shibo Jiang ; et al.
- 关键词：HIV ; Antibody ; Phage display ; gp41 ; Inhibitors ; Vaccines
- 刊名：Journal of Immunological Methods
- 出版年：2006
- 期刊代码：57_00221759
- 类别：imm
- 出版时间：20 December 2006
- 卷：317
- 期：1-2
- 页码：21-30
- 文件大小：387 K
摘要
The HIV envelope glycoprotein (Env) is composed of two non-covalently associated subunits: gp120 and gp41. Panning of phage-displayed antibody libraries against Env-based antigens has resulted mostly in selection of anti-gp120 antibodies. Native gp41 in the absence of gp120 is unstable. The use of gp41 fragments as antigens has resulted in selection of antibodies with only relatively modest neutralizing activity. To enhance selection of antibodies specific for gp41 in the context of the whole Env we developed a methodology termed competitive antigen panning (CAP). Using CAP, we identified a novel gp41-specific human monoclonal antibody (hmAb), m48, from an immune library derived from long-term nonprogressors with high titers of broadly cross-reactive neutralizing antibodies (bcnAbs). Selection of m48 was only successful using CAP and not through the conventional pre-incubation methodology. In assays based on spreading infection in peripheral blood mononuclear cells (PBMCs) m48 neutralized a panel of HIV-1 primary isolates from different clades more potently than the well-characterized broadly cross-reactive HIV-1-neutralizing antibodies IgG1 4E10 and Fab Z13. These results may have implications for the selection of novel gp41-specific bcnAbs and other antibodies, and for the development of HIV-1 inhibitors and vaccine immunogens.